This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Guardant Health’s 8K filing here.
Guardant Health Company Profile
Guardant Health, Inc, a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.
Read More
- Five stocks we like better than Guardant Health
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Short Selling – The Pros and Cons
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Delta Can Fly to New Highs in 2025; Here’s Why
